Hindustan Unilever Ltd
₹ 2,314
1.54%
20 Feb
- close price
About
Hindustan Unilever is in the FMCG business comprising primarily of Home Care, Beauty & Personal Care and Foods & Refreshment segments. The Company has manufacturing facilities across the country and sells primarily in India.[1]
Key Points
- Market Cap ₹ 5,43,813 Cr.
- Current Price ₹ 2,314
- High / Low ₹ 2,660 / 2,044
- Stock P/E 50.8
- Book Value ₹ 208
- Dividend Yield 1.86 %
- ROCE 27.6 %
- ROE 20.6 %
- Face Value ₹ 1.00
Pros
- Company is almost debt free.
- Company has been maintaining a healthy dividend payout of 102%
Cons
- Stock is trading at 11.1 times its book value
- The company has delivered a poor sales growth of 9.65% over past five years.
- Earnings include an other income of Rs.5,340 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 28,019 | 30,806 | 31,061 | 31,890 | 34,525 | 38,224 | 38,785 | 45,996 | 51,193 | 59,144 | 60,469 | 61,469 | 62,213 | |
| 23,532 | 25,600 | 25,312 | 25,843 | 27,249 | 29,587 | 29,185 | 34,672 | 38,690 | 45,512 | 46,279 | 47,180 | 47,930 | |
| Operating Profit | 4,488 | 5,205 | 5,749 | 6,047 | 7,276 | 8,637 | 9,600 | 11,324 | 12,503 | 13,632 | 14,190 | 14,289 | 14,283 |
| OPM % | 16% | 17% | 19% | 19% | 21% | 23% | 25% | 25% | 24% | 23% | 23% | 23% | 23% |
| 837 | 1,285 | 533 | 767 | 507 | 437 | 536 | 286 | 359 | 578 | 884 | 1,599 | 5,340 | |
| Interest | 36 | 17 | 15 | 22 | 20 | 28 | 106 | 108 | 98 | 101 | 302 | 364 | 375 |
| Depreciation | 261 | 287 | 321 | 396 | 478 | 524 | 938 | 1,012 | 1,025 | 1,030 | 1,097 | 1,224 | 1,224 |
| Profit before tax | 5,028 | 6,187 | 5,946 | 6,396 | 7,285 | 8,522 | 9,092 | 10,490 | 11,739 | 13,079 | 13,675 | 14,300 | 18,024 |
| Tax % | 23% | 30% | 30% | 30% | 28% | 29% | 26% | 24% | 25% | 24% | 26% | 26% | |
| 3,867 | 4,315 | 4,137 | 4,490 | 5,237 | 6,036 | 6,738 | 7,954 | 8,818 | 9,962 | 10,114 | 10,644 | 14,990 | |
| EPS in Rs | 17.88 | 19.95 | 19.12 | 20.75 | 24.19 | 27.88 | 31.13 | 33.85 | 37.53 | 42.40 | 43.05 | 45.30 | 63.80 |
| Dividend Payout % | 73% | 75% | 84% | 82% | 82% | 79% | 80% | 120% | 91% | 92% | 98% | 117% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 10% |
| 3 Years: | 6% |
| TTM: | 2% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 8% |
| 3 Years: | 5% |
| TTM: | 4% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 2% |
| 3 Years: | -1% |
| 1 Year: | 8% |
| Return on Equity | |
|---|---|
| 10 Years: | 29% |
| 5 Years: | 21% |
| 3 Years: | 20% |
| Last Year: | 21% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 216 | 216 | 216 | 216 | 216 | 216 | 216 | 235 | 235 | 235 | 235 | 235 | 235 |
| Reserves | 3,061 | 3,508 | 6,063 | 6,274 | 6,859 | 7,443 | 7,815 | 47,199 | 48,525 | 49,986 | 50,738 | 48,918 | 48,715 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 943 | 971 | 1,039 | 1,374 | 1,537 | 1,623 | |
| 9,721 | 9,909 | 7,641 | 8,261 | 10,074 | 10,206 | 11,571 | 19,739 | 20,006 | 20,565 | 24,729 | 27,623 | 28,903 | |
| Total Liabilities | 12,998 | 13,634 | 13,920 | 14,751 | 17,149 | 17,865 | 19,602 | 68,116 | 69,737 | 71,825 | 77,076 | 78,313 | 79,476 |
| 2,422 | 2,458 | 2,914 | 4,024 | 4,142 | 4,343 | 5,056 | 51,027 | 51,034 | 51,405 | 52,379 | 52,907 | 53,149 | |
| CWIP | 320 | 479 | 386 | 203 | 430 | 373 | 513 | 623 | 901 | 1,020 | 915 | 956 | 958 |
| Investments | 3,094 | 3,278 | 2,780 | 3,779 | 3,111 | 2,949 | 1,500 | 2,995 | 4,122 | 3,794 | 5,493 | 4,602 | 7,685 |
| 7,162 | 7,420 | 7,840 | 6,745 | 9,466 | 10,200 | 12,533 | 13,471 | 13,680 | 15,606 | 18,289 | 19,848 | 17,684 | |
| Total Assets | 12,998 | 13,634 | 13,920 | 14,751 | 17,149 | 17,865 | 19,602 | 68,116 | 69,737 | 71,825 | 77,076 | 78,313 | 79,476 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3,724 | 3,272 | 3,974 | 4,953 | 5,913 | 5,728 | 7,305 | 8,957 | 8,964 | 9,626 | 14,884 | 11,606 | |
| -513 | 280 | -51 | -752 | -1,261 | -264 | 1,926 | -1,067 | -1,732 | -1,062 | -4,971 | 6,763 | |
| -2,917 | -3,450 | -4,008 | -4,264 | -4,651 | -5,462 | -6,676 | -9,280 | -7,984 | -8,966 | -9,890 | -13,031 | |
| Net Cash Flow | 294 | 101 | -85 | -63 | 1 | 2 | 2,555 | -1,390 | -752 | -402 | 23 | 5,338 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 11 | 9 | 12 | 11 | 12 | 16 | 10 | 13 | 14 | 17 | 16 | 20 |
| Inventory Days | 83 | 72 | 71 | 65 | 62 | 57 | 63 | 64 | 63 | 53 | 52 | 56 |
| Days Payable | 170 | 146 | 155 | 165 | 186 | 167 | 177 | 162 | 145 | 122 | 139 | 148 |
| Cash Conversion Cycle | -76 | -65 | -71 | -89 | -111 | -94 | -104 | -86 | -67 | -53 | -71 | -72 |
| Working Capital Days | -57 | -55 | -27 | -35 | -39 | -32 | -33 | -33 | -24 | -17 | -23 | -34 |
| ROCE % | 154% | 150% | 120% | 97% | 109% | 119% | 120% | 38% | 24% | 26% | 27% | 28% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
1d - Kotak 'Chasing Growth' investor meet on 25 Feb 2026, physical conference.
-
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
2d - Transcript of the Earnings Conference Call for the quarter ended 31st December, 2025
-
Board Meeting Outcome for Outcome Of The Board Meeting Held On 18Th February 2026
18 Feb - HUL to invest up to ₹2,000 crore over two years to expand premium category manufacturing.
-
Announcement under Regulation 30 (LODR)-Updates on Acquisition
13 Feb - HUL completed acquisition of remaining 49% of Zywie for INR 824 Crore on Feb 13, 2026.
-
Material Update In Connection With The Scheme Of Arrangement - Communication Received From Kwality Wall''s (India) Limited
13 Feb - KWIL 2,34,95,91,262 shares (Re.1) approved for listing; trading starts 16-Feb-2026.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from nse
Concalls
-
Feb 2026Transcript PPT
-
Oct 2025Transcript PPT REC
-
Aug 2025Transcript PPT REC
-
Apr 2025Transcript PPT
-
Jan 2025Transcript PPT
-
Nov 2024TranscriptAI SummaryPPT
-
Oct 2024Transcript PPT
-
Jul 2024Transcript PPT
-
Apr 2024TranscriptPPT
-
Apr 2024Transcript PPT REC
-
Apr 2024TranscriptAI SummaryPPT
-
Mar 2024TranscriptAI SummaryPPT
-
Jan 2024Transcript PPT
-
Oct 2023Transcript PPT
-
Jul 2023Transcript PPT
-
May 2023Transcript PPT REC
-
Jan 2023TranscriptAI SummaryPPT
-
Dec 2022TranscriptAI SummaryPPT
-
Nov 2022TranscriptAI SummaryPPT
-
Nov 2022Transcript PPT
-
Oct 2022TranscriptAI SummaryPPT
-
Jul 2022TranscriptAI SummaryPPT
-
Apr 2022Transcript PPT
-
Apr 2022TranscriptAI SummaryPPT
-
Feb 2022Transcript PPT
-
Dec 2021TranscriptAI SummaryPPT
-
Nov 2021TranscriptAI SummaryPPT
-
Oct 2021TranscriptAI SummaryPPT
-
Sep 2021TranscriptAI SummaryPPT
-
Sep 2021TranscriptAI SummaryPPT
-
Jul 2021TranscriptAI SummaryPPT
-
Jun 2021Transcript PPT
-
Apr 2021TranscriptAI SummaryPPT
-
Feb 2021TranscriptAI SummaryPPT
-
Feb 2021TranscriptAI SummaryPPT
-
Jan 2021TranscriptAI SummaryPPT
-
Dec 2020TranscriptAI SummaryPPT
-
Dec 2020TranscriptAI SummaryPPT
-
Oct 2020TranscriptAI SummaryPPT
-
Sep 2020TranscriptAI SummaryPPT
-
Jul 2020TranscriptAI SummaryPPT
-
Jul 2020TranscriptAI SummaryPPT
-
Apr 2020TranscriptAI SummaryPPT
-
Apr 2020TranscriptAI SummaryPPT
-
Jan 2020TranscriptAI SummaryPPT
-
Dec 2019TranscriptAI SummaryPPT
-
Nov 2019TranscriptAI SummaryPPT
-
Oct 2019TranscriptAI SummaryPPT
-
Aug 2019TranscriptAI SummaryPPT
-
Jul 2019TranscriptAI SummaryPPT
-
Jun 2019TranscriptAI SummaryPPT
-
Jun 2019TranscriptAI SummaryPPT
-
May 2019TranscriptAI SummaryPPT
-
Jan 2019TranscriptAI SummaryPPT
-
Dec 2018TranscriptAI SummaryPPT
-
Dec 2018TranscriptAI SummaryPPT
-
Dec 2018TranscriptAI SummaryPPT
-
Nov 2018TranscriptAI SummaryPPT
-
Oct 2018TranscriptAI SummaryPPT
-
Sep 2018TranscriptAI SummaryPPT
-
Sep 2018TranscriptAI SummaryPPT
-
Jun 2018TranscriptAI SummaryPPT
-
May 2018Transcript PPT
-
May 2018TranscriptAI SummaryPPT
-
Feb 2018TranscriptAI SummaryPPT
-
Feb 2018TranscriptAI SummaryPPT
-
Feb 2018TranscriptAI SummaryPPT
-
Feb 2018TranscriptAI SummaryPPT
-
Jan 2018TranscriptAI SummaryPPT
-
Oct 2017TranscriptAI SummaryPPT
-
Sep 2017TranscriptAI SummaryPPT
-
Sep 2017TranscriptAI SummaryPPT
-
Sep 2017TranscriptAI SummaryPPT
-
Jun 2017TranscriptAI SummaryPPT
-
Jun 2017TranscriptAI SummaryPPT
-
May 2017TranscriptAI SummaryPPT
-
Nov 2016TranscriptAI SummaryPPT
-
Oct 2016TranscriptAI SummaryPPT
-
Jul 2016Transcript PPT
-
Jan 2016TranscriptAI SummaryPPT
Business Segments & Brand Portfolio
The company has a portfolio of over 50 brands, spanning 16 FMCG categories, including 19 brands with a turnover of more than Rs. 1,000 Cr PA. [1] The products are split into the following segments: